TW202220668A - 用於疼痛控制之關節內皮質類固醇的藥學組成物 - Google Patents

用於疼痛控制之關節內皮質類固醇的藥學組成物 Download PDF

Info

Publication number
TW202220668A
TW202220668A TW110128943A TW110128943A TW202220668A TW 202220668 A TW202220668 A TW 202220668A TW 110128943 A TW110128943 A TW 110128943A TW 110128943 A TW110128943 A TW 110128943A TW 202220668 A TW202220668 A TW 202220668A
Authority
TW
Taiwan
Prior art keywords
pharmaceutical composition
intra
osteoarthritis
pain
articular
Prior art date
Application number
TW110128943A
Other languages
English (en)
Chinese (zh)
Inventor
施雪芳
布朗 周
Original Assignee
台灣微脂體股份有限公司
美國商Ｔｌｃ生物醫藥公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 台灣微脂體股份有限公司, 美國商Ｔｌｃ生物醫藥公司 filed Critical 台灣微脂體股份有限公司
Publication of TW202220668A publication Critical patent/TW202220668A/zh

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
TW110128943A 2020-08-05 2021-08-05 用於疼痛控制之關節內皮質類固醇的藥學組成物 TW202220668A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063061395P 2020-08-05 2020-08-05
US63/061,395 2020-08-05

Publications (1)

Publication Number Publication Date
TW202220668A true TW202220668A (zh) 2022-06-01

Family

ID=77519828

Family Applications (1)

Application Number Title Priority Date Filing Date
TW110128943A TW202220668A (zh) 2020-08-05 2021-08-05 用於疼痛控制之關節內皮質類固醇的藥學組成物

Country Status (14)

Country Link
US (1) US12514820B2 (enExample)
EP (1) EP4192426A1 (enExample)
JP (1) JP2023537474A (enExample)
KR (1) KR20230048066A (enExample)
CN (1) CN116348093A (enExample)
AU (1) AU2021320774A1 (enExample)
BR (1) BR112023001926A2 (enExample)
CA (1) CA3187955A1 (enExample)
CL (1) CL2023000315A1 (enExample)
IL (1) IL300354A (enExample)
MX (1) MX2023001410A (enExample)
TW (1) TW202220668A (enExample)
WO (1) WO2022031898A1 (enExample)
ZA (1) ZA202301377B (enExample)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8956600B2 (en) * 2009-08-10 2015-02-17 Taiwan Liposome Co. Ltd. Ophthalmic drug delivery system containing phospholipid and cholesterol
BR112015000174A2 (pt) * 2012-07-05 2017-06-27 Taiwan Liposome Co Ltd método para o tratamento da artrite
EP4389218A3 (en) * 2017-03-14 2024-10-16 Seikagaku Corporation Composition for treating joint disease and kit containing same
EP3820479B1 (en) * 2018-07-09 2026-03-11 Taiwan Liposome Co., Ltd. Methods to reduce complications of intra-articular steroid
IL281513B1 (en) 2018-09-16 2026-07-01 Tlc Biopharmaceuticals Inc Preparations for the treatment of joint pain

Also Published As

Publication number Publication date
BR112023001926A2 (pt) 2023-03-07
AU2021320774A1 (en) 2023-03-09
EP4192426A1 (en) 2023-06-14
MX2023001410A (es) 2023-03-06
US12514820B2 (en) 2026-01-06
ZA202301377B (en) 2026-05-27
CA3187955A1 (en) 2022-02-10
CL2023000315A1 (es) 2023-09-22
KR20230048066A (ko) 2023-04-10
CN116348093A (zh) 2023-06-27
US20230285293A1 (en) 2023-09-14
JP2023537474A (ja) 2023-09-01
IL300354A (en) 2023-04-01
WO2022031898A1 (en) 2022-02-10

Similar Documents

Publication Publication Date Title
US11793755B2 (en) Pharmaceutical composition for intraarticular delivery
TWI857961B (zh) 減少關節內類固醇的併發症之方法
BR112021004880A2 (pt) composições farmacêuticas adequadas para entrega articular e uso das mesmas no tratamento de dor nas articulações
US12514820B2 (en) Pharmaceutical composition of intra-articular corticosteroid for pain control
HK40087158A (en) Pharmaceutical composition of intra-articular corticosteroid for pain control
RU2806023C2 (ru) Способы уменьшения осложнений от внутрисуставного стероида
TW202519194A (zh) 用於疼痛控制之關節內皮質類固醇的微脂體組成物
HK40041258A (en) Methods to reduce complications of intra-articular steroid
HK1219414B (en) Methods of treating arthritis